# clm_44CDC24CAD4E

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: total_equity  
value: 37,481,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2023-12-31  
published: 2023-11-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_5BE6B18DE8F9  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories total equity: 37,481,000,000 United States dollar", as of 2023-09-30 (until 2023-12-31). Claim clm_44CDC24CAD4E, https://asof.is/claim/clm_44CDC24CAD4E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-01)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | total_equity | 37,174,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_44CDC24CAD4E](/claim/clm_44CDC24CAD4E.md) | [clm_2FAA1610921D](/claim/clm_2FAA1610921D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.